This account will give an overview and evaluation of the current advances in mass
spectrometry (MS)-based proteomics platforms and technology. A general review of some …

In recent years, the technology and methods widely available for mass spectrometry (MS)-
based proteomics have increased in power and potential, allowing the study of protein-level …

Biomarker discovery and validation is a central application in current proteomic research to
improve the diagnosis, treatment monitoring and prognosis of many diseases, including …

The extraordinary developments made in proteomic technologies in the past decade have
enabled investigators to consider designing studies to search for diagnostic and therapeutic …

In-depth quantitative proteomic analysis of clinical specimens offers unique and invaluable
insights into their protein composition and biochemical state in physiological and …

The ultimate objective of clinical proteomics is the successful discovery, validation and
translation of biomarkers, together with new therapeutic targets into medical practices. New …

In recent years, mass spectrometry (MS) has been recognized as a 'Gold Standard'tool for
the identification and analysis of individual proteins in expression proteomics studies …

MS is an important analytical tool in clinical proteomics, primarily in the disease‐specific
discovery, identification and characterisation of proteomic biomarkers and patterns. MS …

Proteomics has been proposed as one of the key technologies in the postgenomic era. So
far, however, the comprehensive analysis of cellular proteomes has been a challenge …

Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …